Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 23
2005 72
2006 87
2007 102
2008 113
2009 129
2010 117
2011 155
2012 167
2013 235
2014 367
2015 435
2016 564
2017 595
2018 602
2019 661
2020 877
2021 900
2022 845
2023 872
2024 893
2025 553

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,899 results

Results by year

Filters applied: . Clear all
Page 1
Kupffer cell programming by maternal obesity triggers fatty liver disease.
Huang H, Balzer NR, Seep L, Splichalova I, Blank-Stein N, Viola MF, Franco Taveras E, Acil K, Fink D, Petrovic F, Makdissi N, Bayar S, Mauel K, Radwaniak C, Zurkovic J, Kayvanjoo AH, Wunderling K, Jessen M, Yaghmour MH, Kenner L, Ulas T, Grein S, Schultze JL, Scott CL, Guilliams M, Liu Z, Ginhoux F, Beyer MD, Thiele C, Meissner F, Hasenauer J, Wachten D, Mass E. Huang H, et al. Nature. 2025 Jun 18. doi: 10.1038/s41586-025-09190-w. Online ahead of print. Nature. 2025. PMID: 40533564
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. N Engl J Med. 2025 Jun 18. doi: 10.1056/NEJMoa2415434. Online ahead of print. N Engl J Med. 2025. PMID: 40532178
Multi-omics and functional characterization of the tumor-killing capacity of Imiquimod-activated plasmacytoid dendritic cells.
Gastaldi T, Novoszel P, Sanlorenzo M, de Sá Fernandes C, Mohr T, Krauß D, Blauensteiner B, Holcmann M, Barozzi I, Sibilia M. Gastaldi T, et al. iScience. 2025 May 14;28(6):112670. doi: 10.1016/j.isci.2025.112670. eCollection 2025 Jun 20. iScience. 2025. PMID: 40530418 Free PMC article.
Plasmacytoid dendritic cells (pDCs) are a subset of DCs generally associated with poor prognosis of cancer patients. However, upon TLR7/8 activation by imiquimod, pDCs have been shown to acquire tumor-killing abilities. ...These results will be instrumental to design furth …
Plasmacytoid dendritic cells (pDCs) are a subset of DCs generally associated with poor prognosis of cancer patients. However, upon TL …
Enhanced vascular inflammation in patients with advanced prostate cancer receiving hormone therapy.
Einspieler H, Muin D, Langrate IK, Schmitl S, Spielvogel CP, Fueger BJ, Li X, Kramer G, Shariat SF, Hacker M, Rasul S. Einspieler H, et al. Eur J Nucl Med Mol Imaging. 2025 Jun 17. doi: 10.1007/s00259-025-07409-6. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 40526128
PURPOSE: While blocking androgen production and action effectively slows prostate cancer (PCa) progression, it is associated with significant side effects, including an increased risk of cardiovascular disease. ...
PURPOSE: While blocking androgen production and action effectively slows prostate cancer (PCa) progression, it is associated with sig …
Site-Selectively Functionalized Albumin with DFO*Maleimide for 89Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice.
Kronberger J, Balber T, Schueffl H, Wahrmann R, Federa A, Gradl M, Brandt MR, Wanek T, Mitterhauser M, Kowol CR, Mindt TL, Heffeter P. Kronberger J, et al. J Med Chem. 2025 Jun 17. doi: 10.1021/acs.jmedchem.5c00803. Online ahead of print. J Med Chem. 2025. PMID: 40526060
In this study, we site-selectively radiolabeled HSA with zirconium-89 ((89)Zr), using the octadentate chelator DFO*, to provide an imaging probe with enhanced stability and sufficient half-life to elucidate the long-term (tumoral) albumin homeostasis. [(89)Zr]Zr-DFO*malHSA demons …
In this study, we site-selectively radiolabeled HSA with zirconium-89 ((89)Zr), using the octadentate chelator DFO*, to provide an imaging p …
Update on Liquid Biopsy.
Mayerhoefer ME, Kienzle A, Woo S, Vargas HA. Mayerhoefer ME, et al. Radiology. 2025 Jun;315(3):e241030. doi: 10.1148/radiol.241030. Radiology. 2025. PMID: 40525978 Review.
It has received considerable attention as a minimally invasive tool for whole-body tumor interrogation for use in patients with cancer. It poses an attractive and potentially cost-effective alternative to invasive tissue sampling through tissue biopsies, especially serial …
It has received considerable attention as a minimally invasive tool for whole-body tumor interrogation for use in patients with cancer …
Clonal hematopoiesis in patients with cancer and its association with risk of thrombosis and prognosis of disease.
Englisch C, Jäger R, Gassner J, Assinger A, Preusser M, Valent P, Pabinger I, Ay C. Englisch C, et al. Res Pract Thromb Haemost. 2025 May 8;9(4):102882. doi: 10.1016/j.rpth.2025.102882. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40524734 Free PMC article.
BACKGROUND: Patients with cancer are at high risk for cardiovascular events, especially venous and arterial thromboembolism (VTE/ATE). ...However, there is limited insight into the impact of CH on thrombosis risk in patients with cancer. OBJECTIVES: The aim of this …
BACKGROUND: Patients with cancer are at high risk for cardiovascular events, especially venous and arterial thromboembolism (VTE/ATE) …
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study.
Kaufmann E, Antonelli L, Afferi L, Asero V, Prata F, Rebuffo S, Veccia A, Culpan M, Tully K, Ribeiro L, Roumeguere T, Hendricksen K, Lambertini L, Pichler R, Pavan N, Teoh JY, Roumiguié M, Schulz GB, Soria F, AlGhamlas A, Desprez PE, Orecchia L, Poyet C, Alrumayyan M, Rink M, Zamboni S, Montes MR, Okoye S, Re ML, Krajewski W, Lavallee L, Wettstein MS, Moschini M, Fankhauser CD. Kaufmann E, et al. Eur Urol Open Sci. 2025 Jun 4;77:10-18. doi: 10.1016/j.euros.2025.05.002. eCollection 2025 Jul. Eur Urol Open Sci. 2025. PMID: 40524687 Free PMC article.
BACKGROUND AND OBJECTIVE: Preoperative anemia is common in patients undergoing radical cystectomy for bladder cancer, but its prevalence and impact on outcomes remain poorly characterized across different health care settings. ...METHODS: We retrospectively analyzed 4886 p …
BACKGROUND AND OBJECTIVE: Preoperative anemia is common in patients undergoing radical cystectomy for bladder cancer, but its prevale …
7,899 results